Opus Point Partners LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Opus Point Partners LLC
CIK #0001503454, 0001600175
CIK Period
0001503454 0001600175
Sector Form 13F Holdings Value ($M)
Mettler Toledo International INC/ 2.3
Bristol Myers Squibb Co 1.7
Illumina Inc 1.4
Vertex Pharmaceuticals Inc / Ma 1.4
ISIS Pharmaceuticals Inc 1.2
Alnylam Pharmaceuticals Inc 1.1
Qiagen NV 1.0
Coronado Biosciences Inc 0.9
Proqr Therapeutics NV 0.8
Incyte Corp 0.8
Regeneron Pharmaceuticals Inc 0.7
BioMarin Pharmaceutical Inc 0.7
Ascendis Pharma A/S 0.6
Uniqure NV 0.6
CRISPR Therapeutics AG 0.5
Amarin Corp PLC UK 0.5
Boundless Bio Inc 0.5
Biohaven Ltd 0.5
 
 
 
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2026
3 [0001503454]
SC 13D [0001503454]
SC 13G [0001503454]
13F-HR [0001600175]
Form 13D/13G Filer Form 13D/13G Subject Filed
Opus Point Partners LLC Anthera Pharmaceuticals Inc [2012-08-27]
Opus Point Partners LLC Manhattan Pharmaceuticals Inc [2012-01-10]
Form 3/4/5 Subject 2011 - 2026
Opus Point Healthcare Innovations Offshore Fund Ltd
FBIO Acquisition Inc
Coronado Biosciences Inc
Opus Point Partners LLC
National Holdings Corp
Weiss Michael S
Rosenwald Lindsay A MD
TG Therapeutics Inc
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com